1. petezahut
2. wlo7669
3. NotSoOldTimer
1.wlo7669 03/30/2018
What does that mean?
2.wlo7669 06/29/2018
FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers
3.wlo7669 04/17/2018
Aptose Presents New Preclinical Data on CG'806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting
4.petezahut 03/30/2018
Aptose Biosciences Establishes New At-the-Market Facility
5.petezahut 05/07/2018
Aptose Exercises Early Option for CG-806 License From CrystalGenomics
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW